erastin - Whitehead Institute for Biomedical Research, Dana-Farber Cancer Institute, Columbia University, Prolexys
sorafenib - Generic mfg.
CKS2 induces autophagy-mediated glutathione metabolic reprogramming to facilitate ferroptosis resistance in colon cancer. (PubMed, Mol Med) - Nov 18, 2024 - "CKS2 suppresses ferroptosis in CC by modulating GSH metabolism in both in vitro and in vivo settings. These findings offer new insights into targeting CKS2 for CC treatment and shed light on the mechanism of ferroptosis in CC." 
Journal • Colon Cancer • Colorectal Cancer • Oncology • Solid Tumor • CKS2 • GPX4
http://www.ncbi.nlm.nih.gov/pubmed/39548421
 
Chengfeng Fang; Dinghai Luo; Jiaju Han; Leilei Yang; Lingyan Shen; Ruili Zhang; ShenKang Zhou; Yan Chen; Yufeng Ren; Zaiping Yang
 
Nov 18, 2024
 
Prev Next